Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Emerald Health Therapeutics Inc (EMH.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 605,011
  • Shares Outstanding, K 136,571
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta 1.89
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.44
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.15
  • Most Recent Earnings -0.04 on 06/30/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.270 +3.75%
on 09/28/18
5.240 -15.46%
on 10/16/18
-0.790 (-15.13%)
since 09/18/18
3-Month
2.505 +76.85%
on 07/20/18
5.920 -25.17%
on 09/11/18
+1.750 (+65.30%)
since 07/18/18
52-Week
1.380 +221.01%
on 10/20/17
9.680 -54.24%
on 01/23/18
+3.000 (+209.79%)
since 10/18/17

Most Recent Stories

More News
Emerald Health Therapeutics Files 17 Patent Applications Covering Defined Dose(TM) Cannabis Products

Unique Emerald cannabinoid formulations and dosage forms focused on providing consumers precise and differentiated products based on protected intellectual property

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
Experion Completes Second Sale to Emerald Health

Vancouver, British Columbia - Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce that its wholly owned subsidiary, Experion Biotechnologies...

VIRFF : 0.8004 (-5.77%)
EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
VIR.VN : 1.000 (-4.76%)
Emerald Health Therapeutics Promotes Paul R. Dillman, Jr. to Executive Vice President of Global Sales and Marketing

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald") today announced the promotion of Paul R. Dillman, Jr. to Executive Vice President of Global Sales and Marketing. Mr. Dillman previously...

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
Emerald Health Therapeutics' Subsidiary Northern Vine Receives International Government Approvals and Completes Import and Export of Cannabis Oils for Research & Development

Northern Vine receives approval from Health Canada to export to USA and import isolated CBD from the Netherlands, Colombia and China, with corresponding national permits

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
Emerald Health Therapeutics' Wholly Owned Subsidiary Northern Vine to Participate in Series of Cannabis Testing Seminars Hosted by Thermo Fisher Scientific

Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH; OTCQX:EMHTF) ("Emerald") today announced that Northern Vine Canada Inc. (Northern Vine), a wholly owned subsidiary of Emerald, will participate...

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products

VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald") has entered into a research agreement with VivaCell Biotechnologies...

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
Emerald Health Therapeutics Secures Long-term Supply of Hemp for CBD Extraction

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald") has agreed to purchase from Emerald Health Hemp Inc. (EHH) CBD-containing hemp biomass for extraction into CBD oil. EHH has established...

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
Innovative Technology Advancements for Booming Cannabis Business Becoming More Lucrative by the Day

MarketNewsUpdates.com News Commentary

EMHTF : 3.3800 (-3.52%)
PKG.CN : 0.430 (+10.26%)
OGRMF : 5.4900 (-2.11%)
OGI.VN : 7.190 (-2.04%)
JUJU.CN : 0.220 (-10.20%)
SPN.VN : 0.080 (+6.67%)
FSDDF : 0.4500 (-10.00%)
PTNYF : 0.3385 (+11.09%)
EMH.VN : 4.430 (-2.85%)
HUGE.CN : 0.590 (-7.81%)
GEATF : 0.1750 (-2.51%)
Emerald Health Therapeutics Named as Cannabis Supplier by Newfoundland Labrador Liquor Corporation to Provide Adult-Use Cannabis Products

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald") has been selected as an authorized cannabis supplier by the Newfoundland Labrador Liquor Corporation ("NLC") to supply cannabis products...

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)
Emerald Health Therapeutics Confirms Supply Agreement with Ontario Cannabis Retail Corporation to Supply Adult-Use Cannabis Products

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald") today announced that it has been selected as an approved supplier by the Ontario Cannabis Retail Corporation, operating as the Cannabis...

EMHTF : 3.3800 (-3.52%)
EMH.VN : 4.430 (-2.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Key Turning Points

2nd Resistance Point 4.797
1st Resistance Point 4.613
Last Price 4.430
1st Support Level 4.323
2nd Support Level 4.217

See More

52-Week High 9.680
Fibonacci 61.8% 6.509
Fibonacci 50% 5.530
Fibonacci 38.2% 4.551
Last Price 4.430
52-Week Low 1.380

See More

Business Summary

Emerald Health Therapeutics Inc is a Canada based Health Canada Licensed Producer of medical cannabis. Through its subsidiary, it is engaged in the production and sale of medical marihuana.

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar